HK1010985A1 - The use of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) for the preparation of a medicament for the treatment of arboviruses - Google Patents

The use of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) for the preparation of a medicament for the treatment of arboviruses

Info

Publication number
HK1010985A1
HK1010985A1 HK98111842A HK98111842A HK1010985A1 HK 1010985 A1 HK1010985 A1 HK 1010985A1 HK 98111842 A HK98111842 A HK 98111842A HK 98111842 A HK98111842 A HK 98111842A HK 1010985 A1 HK1010985 A1 HK 1010985A1
Authority
HK
Hong Kong
Prior art keywords
ribofuranosyl
carboxamide
triazole
arboviruses
ribavirin
Prior art date
Application number
HK98111842A
Other languages
English (en)
Inventor
Robert Angus Smith
Humberto Fernandes
Original Assignee
Vira Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1010985(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vira Tek Inc filed Critical Vira Tek Inc
Publication of HK1010985A1 publication Critical patent/HK1010985A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HK98111842A 1984-10-29 1998-11-09 The use of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) for the preparation of a medicament for the treatment of arboviruses HK1010985A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66625284A 1984-10-29 1984-10-29

Publications (1)

Publication Number Publication Date
HK1010985A1 true HK1010985A1 (en) 1999-07-02

Family

ID=24673430

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98111842A HK1010985A1 (en) 1984-10-29 1998-11-09 The use of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) for the preparation of a medicament for the treatment of arboviruses

Country Status (19)

Country Link
EP (3) EP0181050A3 (xx)
JP (1) JPH0713019B2 (xx)
KR (1) KR860003018A (xx)
AT (1) ATE204173T1 (xx)
AU (1) AU584333B2 (xx)
BE (1) BE902199A (xx)
CA (1) CA1261265A (xx)
DD (1) DD261094A5 (xx)
DE (3) DE10299005I2 (xx)
ES (1) ES8704962A1 (xx)
FR (1) FR2572286B1 (xx)
GB (1) GB2166050B (xx)
HK (1) HK1010985A1 (xx)
LU (1) LU85854A1 (xx)
NL (1) NL300083I1 (xx)
NZ (1) NZ212510A (xx)
PH (1) PH22534A (xx)
PT (1) PT81387B (xx)
ZA (1) ZA858237B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
JP2792246B2 (ja) * 1991-01-31 1998-09-03 信越半導体株式会社 単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
MXPA01007211A (es) * 1999-01-29 2002-05-06 Icn Pharmaceuticals Modulacion de la respuesta inmune por ribavirina.
US6720000B2 (en) 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
EA201692515A1 (ru) 2014-06-23 2017-05-31 Сановель Илач Санайи Ве Тиджарет А.Ш. Новая фармацевтическая композиция на основе софосбувира и рибавирина
EA201692514A1 (ru) 2014-06-23 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. Фармацевтические композиции на основе софосбувира и рибавирина с модифицированным высвобождением
EP2959901A1 (en) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of sofosbuvir and ribavirin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
AR205339A1 (es) * 1973-03-12 1976-04-30 Icn Pharmaceuticals Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles

Also Published As

Publication number Publication date
ES8704962A1 (es) 1987-04-16
JPH0713019B2 (ja) 1995-02-15
JPS61109723A (ja) 1986-05-28
EP0643970A3 (en) 1997-07-09
DE3588232D1 (de) 2001-09-20
EP0643970B1 (en) 2001-08-16
AU584333B2 (en) 1989-05-25
EP0383361A3 (en) 1993-06-16
DD261094A5 (de) 1988-10-19
EP0383361A2 (en) 1990-08-22
PT81387A (en) 1985-11-01
EP0181050A3 (en) 1987-10-21
ZA858237B (en) 1988-02-24
GB2166050A (en) 1986-04-30
CA1261265A (en) 1989-09-26
BE902199A (fr) 1985-07-31
ATE204173T1 (de) 2001-09-15
ES548303A0 (es) 1987-04-16
DE10299005I1 (de) 2002-05-08
EP0643970A2 (en) 1995-03-22
DE181050T1 (de) 1986-12-18
GB2166050B (en) 1989-08-16
FR2572286B1 (fr) 1990-03-23
DE10299005I2 (de) 2004-07-01
EP0181050A2 (en) 1986-05-14
LU85854A1 (fr) 1985-12-16
KR860003018A (ko) 1986-05-19
NZ212510A (en) 1989-04-26
FR2572286A1 (fr) 1986-05-02
DE3588232T2 (de) 2002-06-13
GB8509689D0 (en) 1985-05-22
NL300083I1 (nl) 2002-05-01
PT81387B (pt) 1987-11-11
AU4180785A (en) 1986-05-08
PH22534A (en) 1988-10-17

Similar Documents

Publication Publication Date Title
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
MY130035A (en) Antiviral compounds
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
DK0973735T3 (da) Polyaromatiske antivirale præparater
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
HK1010985A1 (en) The use of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) for the preparation of a medicament for the treatment of arboviruses
NO965556L (no) Trippelkombinasjon mot HIV
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
NO993997L (no) Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol
ATE153533T1 (de) Zubereitungen, die acyclovir-ähnliche verbindungen und 2'-vinylsubstituierte nukleosidanaloge enthalten, zur behandlung viraler infektionen
UA23352A (uk) beta- D- ГЛЮКОЗАМОHІЙHА СІЛЬ alРha-БРОМІЗОВАЛЕРІАHОВОЇ КИСЛОТИ, ЯКА МАЄ ПРОТИВІРУСHУ АКТИВHІСТЬ ВІДHОСHО ВІРУСУ ВЕЗИКУЛЯРHОГО СТОМАТИТУ, ВІРУСУ ПРОСТОГО ГЕРПЕСУ ТА КОРОHАВІРУСУ
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
MX9706942A (es) Compuestos quimicos.
IT8522576A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori, muscolari e articolari.
UA10754A (uk) Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу
GEU1998399Y (en) Preparation “Pheroservit-1” for Increasing the Resistivity of Young Stock Against Anemia
GEP19991605B (en) Inhibitor, Its Obtaining and Use

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20050415